Table 2.
Baseline exercise test characteristics and the percentage of subjects on medications according to the quarters of ECP.
| Overall | Q1 | Q2 | Q3 | Q4 | p | |
|---|---|---|---|---|---|---|
| VO2max (mL/min) | 2400 ± 636 | 1719 ± 393 | 2224 ± 319 | 2566 ± 341 | 3095 ± 491 | <0.001 |
| VO2max (mL/kg/min) | 30.2 ± 8.0 | 22.4 ± 5.5 | 28.1 ± 4.8 | 32.4 ± 5.4 | 37.7 ± 6.9 | <0.001 |
| Peak systolic blood pressure (mmHg) | 202.0 ± 28.0 | 206.0 ± 32.0 | 207.0 ± 27.6 | 201.0 ± 25.3 | 193.0 ± 24.0 | <0.001 |
| Acetylsalicylic acid (%) | 7.0 | 8.8 | 7.1 | 6.1 | 5.8 | |
| Beta-blockers (%) | 17.6 | 29.2 | 18.8 | 12.5 | 9.7 | |
| Drugs for cholesterol (%) | 0.6 | 1.5 | 0.5 | 0.2 | 0.2 |
Notes: Data are presented as mean ± SD. Q1: ECP < 9.84 mL/mmHg; Q2: ECP = 9.84–11.64 mL/mmHg; Q3: ECP = 11.65–13.92 mL/mmHg; Q4: ECP >13.92 mL/mmHg.
Abbreviations: ECP = exercise cardiac power; Q = quartile; VO2max = maximal oxygen uptake.